Johnson & Johnson Poised For A Muted Q2? : vimarsana.com

We expect the company’s revenues to come in at $24.6 billion, marginally below the consensus estimate of $24.7 billion.

Related Keywords

, Johnson , Abiomed , Johnson Earnings Preview , Consumer Healthcare , Johnson Peers , Johnson Amp , Medtech , Jnj Stock , Jnj Revenue , J Amp , Jnj Q2 , Jnj Valuation ,